Salamat F, Siavashpour Z, Sadeghi M, Jaberi R, Gholami S
J Contemp Brachytherapy. 2024; 16(4):279-288.
PMID: 39628822
PMC: 11609852.
DOI: 10.5114/jcb.2024.143609.
Harris P, Farberg A, Hopkins J, Ma L, Serure D, Robbins B
Oncol Ther. 2024; 13(1):31-48.
PMID: 39572513
PMC: 11880453.
DOI: 10.1007/s40487-024-00310-6.
Patro K, Avinash A, Banidutta A, Kundu C, Bhattacharya P, Pilaka V
Radiat Oncol J. 2024; 42(2):154-159.
PMID: 38946078
PMC: 11215503.
DOI: 10.3857/roj.2023.00682.
Poltorak M, Banatkiewicz P, Poltorak L, Sobolewski P, Zimon D, Szwast M
J Contemp Brachytherapy. 2024; 16(2):156-169.
PMID: 38808207
PMC: 11129648.
DOI: 10.5114/jcb.2024.137357.
Patel P, Pixley J, Dibble H, Feldman S
Dermatol Ther (Heidelb). 2023; 13(9):1959-1971.
PMID: 37531073
PMC: 10442296.
DOI: 10.1007/s13555-023-00989-x.
Physical parameters in thermal imaging of basal cell cancer patients treated with high-dose-rate brachytherapy - first study.
Kapek L, Cholewka A, Szurko A, Stanek A, Szlag M, Slosarek K
Rep Pract Oncol Radiother. 2023; 27(6):1019-1025.
PMID: 36632301
PMC: 9826656.
DOI: 10.5603/RPOR.a2022.0114.
Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases.
Yeh J, Wan M, Alloo A, Ibrahim N, Buzurovic I, Cohen J
JAAD Case Rep. 2022; 31:62-65.
PMID: 36505038
PMC: 9731864.
DOI: 10.1016/j.jdcr.2022.09.006.
Current advances in the selection of adjuvant radiotherapy regimens for keloid.
Wang W, Zhao J, Zhang C, Zhang W, Jin M, Shao Y
Front Med (Lausanne). 2022; 9:1043840.
PMID: 36425105
PMC: 9679021.
DOI: 10.3389/fmed.2022.1043840.
Non-melanoma Skin Cancer Treated by Contact High-dose-rate Radiotherapy (Brachytherapy): A Mono-institutional Series and Literature Review.
Tagliaferri L, Ciardo F, Fionda B, Casa C, Di Stefani A, Lancellotta V
In Vivo. 2021; 35(4):2313-2319.
PMID: 34182511
PMC: 8286496.
DOI: 10.21873/invivo.12505.
Individualized mould-based high-dose-rate brachytherapy for perinasal skin tumors: technique evaluation from a dosimetric point of view.
Scherf C, Licher J, Mletzko C, Trommel M, Tselis N, Chatzikonstantinou G
J Contemp Brachytherapy. 2021; 13(2):179-187.
PMID: 33897792
PMC: 8060955.
DOI: 10.5114/jcb.2021.105286.
Complex and prolonged skin toxicity after superficial brachytherapy for basal cell carcinoma on the lower leg.
Rembielak A
J Contemp Brachytherapy. 2020; 12(4):406-411.
PMID: 33293981
PMC: 7690222.
DOI: 10.5114/jcb.2020.98121.
A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma: Case Reports and Review of the Literature.
Passarelli A, Galdo G, Aieta M, Fabrizio T, Villonio A, Conca R
Int J Mol Sci. 2020; 21(22).
PMID: 33202689
PMC: 7696523.
DOI: 10.3390/ijms21228596.
Melanoma and non-melanoma skin cancer among patients who attended at King Khalid University Hospital in Riyadh, Saudi Arabia from 2007 - 2018.
Arab K, AlRuhaili A, AlJohany T, AlHammad R
Saudi Med J. 2020; 41(7):709-714.
PMID: 32601638
PMC: 7502929.
DOI: 10.15537/smj.2020.7.25138.
Sex-specific differences in patients with nonmelanoma skin cancer of the pinna.
Moser U, Andrianakis A, Pondorfer P, Wolf A, Graupp M, Weiland T
Head Neck. 2020; 42(9):2414-2420.
PMID: 32369257
PMC: 7496743.
DOI: 10.1002/hed.26237.
Combined interstitial and surface high-dose-rate brachytherapy treatment of squamous cell carcinoma of the hand.
Kim D, Buzurovic I, Mahal B, Hwang W, Oladeru O, OFarrell D
J Contemp Brachytherapy. 2020; 12(1):48-52.
PMID: 32190070
PMC: 7073341.
DOI: 10.5114/jcb.2020.92408.
Treatment of keratinocyte carcinoma in elderly patients - a review of the current literature.
Leus A, Frie M, Haisma M, Terra J, Plaat B, Steenbakkers R
J Eur Acad Dermatol Venereol. 2020; 34(9):1932-1943.
PMID: 32030838
PMC: 7496368.
DOI: 10.1111/jdv.16268.
Surface Mould Brachytherapy for Skin Cancers: The British Columbia Cancer Experience.
Casey S, Awotwi-Pratt J, Bahl G
Cureus. 2020; 11(12):e6412.
PMID: 31988814
PMC: 6970095.
DOI: 10.7759/cureus.6412.
Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma.
Vavassori A, Riva G, Durante S, Fodor C, Comi S, Cambria R
J Contemp Brachytherapy. 2019; 11(5):443-448.
PMID: 31749853
PMC: 6854866.
DOI: 10.5114/jcb.2019.88619.
High Dose Rate 192-Ir-Brachytherapy for Basal Cell Carcinoma of the Skin using a 3D Printed Surface Mold.
Casey S, Bahl G, Awotwi-Pratt J
Cureus. 2019; 11(6):e4913.
PMID: 31417833
PMC: 6693796.
DOI: 10.7759/cureus.4913.
Consensus Guidelines on the Use of Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancers and Keloids.
Nestor M, Berman B, Goldberg D, Cognetta Jr A, Gold M, Roth W
J Clin Aesthet Dermatol. 2019; 12(2):12-18.
PMID: 30881578
PMC: 6415702.